Douglas B. Evans, MD

Publications

• Tips for authors of surgical manuscripts from senior reviewers.

  (Malangoni MA, Evans DB, Prinz RA, Hodin RA, Rege R, Harken AH.) Surgery. 2021 Jul;170(1):341-344 PMID: 33494949 SCOPUS ID: 2-s2.0-85099805332 01/27/2021

• Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods.

  (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S.) Am J Surg. 2021 07;222(1):10-17 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020

• Ten-year experience in optimizing neoadjuvant therapy for localized pancreatic cancer-Medical college of Wisconsin perspective.

  (Ward EP, Evans DB, Tsai S.) J Surg Oncol. 2021 May;123(6):1405-1413 PMID: 33831252 SCOPUS ID: 2-s2.0-85103999698 04/09/2021

• Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy.

  (Evans DB.) Surgery. 2021 05;169(5):1032-1033 PMID: 32868112 SCOPUS ID: 2-s2.0-85090066021 09/02/2020

• Total Neoadjuvant Therapy for Operable Pancreatic Cancer.

  (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S.) Ann Surg Oncol. 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020

• An Institutional experience with primary hyperparathyroidism in the elderly over two decades.

  (O'Sullivan K, Yen TWF, Doffek K, Dream S, Mazotas I, Evans DB, Wang TS.) Am J Surg. 2021 Jan 30 PMID: 33551115 SCOPUS ID: 2-s2.0-85100630649 02/09/2021

• Commentary: Surgery for locally advanced pancreatic cancer after neoadjuvant therapy

  (Evans DB.) Surgery (United States). May 2021;169(5):1032-1033 SCOPUS ID: 2-s2.0-85090066021 05/01/2021

• Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level.

  (Zimmermann MT, Mathison AJ, Stodola T, Evans DB, Abrudan JL, Demos W, Tschannen M, Aldakkak M, Geurts J, Lomberk G, Tsai S, Urrutia R.) Front Oncol. 2021;11:606820 PMID: 33747920 PMCID: PMC7973372 SCOPUS ID: 2-s2.0-85102941394 03/23/2021

• Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA.

  (Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB.) Clin Cancer Res. 2021 Jan 01;27(1):226-236 PMID: 33093149 PMCID: PMC7785673 SCOPUS ID: 2-s2.0-85100339220 10/24/2020

• Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy.

  (Kim RY, Evans DB, Christians KK.) Hepatobiliary Surg Nutr. 2020 Aug;9(4):497-500 PMID: 32832502 PMCID: PMC7423551 08/25/2020

• Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer

  (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S.) HPB. December 2020;22(12):1745-1752 SCOPUS ID: 2-s2.0-85083782398 12/01/2020

• Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer

  (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S.) Surgery (United States). September 2020;168(3):440-447 SCOPUS ID: 2-s2.0-85087345792 09/01/2020